G. Robinet

14.3k citations
110 papers · 3.0k · 1 hit paper · h-index 23

Impact in

  • Oncology top 1%
    • Lung Cancer Research Studies
    • Cancer Immunotherapy and Biomarkers
    • Colorectal Cancer Treatments and Studies
    • Lung Cancer Treatments and Mutations
    • Lung Cancer Diagnosis and Treatment
    • Brain Metastases and Treatment

Papers in

    • Lung Cancer Treatments and Mutations 74
    • Lung Cancer Diagnosis and Treatment 19
    • Brain Metastases and Treatment 11
    • Lung Cancer Research Studies 48
    • Cancer Immunotherapy and Biomarkers 20
    • Colorectal Cancer Treatments and Studies 13
    • Cancer Treatment and Pharmacology 12

G. Robinet

104 papers receiving 3.0k citations

Hit Papers

Randomized Phase II Trial of Onartuzumab in Combination With Erlotinib in Patients With Advanced Non–Small-Cell Lung Cancer 2013 · 370 citations
3700+4+8Years since publication100200300

Peers

G. Robinet
Comparison fields: 5 of 90
  • Oncology 2.1k
  • Pulmonary and Respiratory Medicine 2.3k
  • Hepatology 240
  • Cancer Research 325
  • Otorhinolaryngology 80
Replace Dominique Grunenwald with:
Dominique Grunenwald France
Russell F. DeVore United States
Ichiro Takata Japan
Hirohito Tada Japan
Shuichi Hironaka Japan
Jerome C. Landry United States
Francisco Robert United States
Panos Fidias United States
S. Kakolyris Greece
Elizabeth Poplin United States
G. Robinet relative to Dominique Grunenwald France Dominique Grunenwald's profile →
Citations per field
00.5×3.4×
Dominique Grunenwald · 1×
Citations per year

Countries citing papers authored by G. Robinet

Since Specialization
Citations

This map shows the geographic impact of G. Robinet's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by G. Robinet with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites G. Robinet more than expected).

Fields of papers citing papers by G. Robinet

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by G. Robinet. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by G. Robinet. The network helps show where G. Robinet may publish in the future.

Co-authors

The 25 scholars most cited alongside G. Robinet, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with G. Robinet Line = papers co-authored together G. Robinet links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 110 papers — load more, or switch the sort, to bring in the rest.

#Work
1 2005411
2
Randomized Phase II Trial of Onartuzumab in Combination With Erlotinib in Patients With Advanced Non–Small-Cell Lung Cancer
Hit paper breakdown →
2013370
3 2007213
4 2001198
5 2011181
6 2000177
7 2011149
8 2001133
9 2014132
10 201874
11 201761
12 202157
13 201950
14 202040
15 200635
16 200131
17 200230
18 200429
19 201027
20 201327

About G. Robinet

G. Robinet is a scholar working on Pulmonary and Respiratory Medicine, Oncology, Molecular Biology, Epidemiology and Cancer Research, having authored 110 papers that have together received 3.0k indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (74 papers), Lung Cancer Research Studies (48 papers), Cancer Immunotherapy and Biomarkers (20 papers), Lung Cancer Diagnosis and Treatment (19 papers), Colorectal Cancer Treatments and Studies (13 papers), Cancer Treatment and Pharmacology (12 papers), Neuroendocrine Tumor Research Advances (12 papers) and Brain Metastases and Treatment (11 papers). The work is most often cited by research in Oncology (2.1k citations), Pulmonary and Respiratory Medicine (2.3k citations), Hepatology (240 citations), Cancer Research (325 citations) and Otorhinolaryngology (80 citations). G. Robinet has collaborated with scholars based in France, United States and Italy. Frequent co-authors include M. Pérol, A. Vergnenègre, P. Thomas, P. Fournel, Fabrice Barlési, H. Léna, H. Léna, D. Paillotin, F. Mornex and Rodryg Ramlau. Their work appears in journals such as Lung Cancer, Annals of Oncology, Journal of Clinical Oncology, Journal of Thoracic Oncology and Targeted Oncology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact